Newsletter | September 17, 2026

09.17.26 -- How Leading Teams Reduce Risk And Improve Readiness

How Predictive Analytics Can De-Risk Complex OSD Development

Gain a clearer path to launch through predictive modeling, advanced material characterization, and process insights that strengthen manufacturing preparedness.

 

What It Takes To Accelerate High-Potency Oncology Therapies To Market

Discover how disciplined containment, proactive risk management, and collaboration accelerate complex oncology programs under tight timelines while protecting quality, safety, and global launch readiness.

 

Can Value By Design Help Bring Your Drug To Market Faster?

Learn how a value-by-design approach can improve decision-making, reduce development uncertainty, optimize resources, and accelerate the journey to commercialization.

 

VIDEO FEATURE

Recipharm Capabilities Update May 2026: Highly Potent Drug Development & Manufacturing

Bringing a high potency product to market is rarely straightforward, especially when timelines slip, API is scarce and processes don't scale as planned.

 

UPCOMING EVENT

 

 

SOLUTIONS